Calidi Biotherapeutics, the NYSE American-listed oncology company developing virus-based immunotherapies, signed a 44-month lease for 9,038 square feet of office and laboratory space...
ByThe RegistryNovember 1, 2026 
Signup for news and special announcements!
You have successfully joined our subscriber list.
Error: Contact form not found.